Overview Dividends

(TBI) TrueBlue - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US89785X1019

Staffing, Recruitment, Outsourcing, Workforce, Contingent

TBI EPS (Earnings per Share)

EPS Growth (3Y CAGR): -62.02%
EPS Trend (3Y Correlation): -58.2%

TBI Revenue

Revenue Growth (3Y CAGR): -8.92%
Revenue Trend (3Y Correlation): -77.8%

Risk via 10d forecast
Volatility	77.2%
Value at Risk 5%th	109%
Relative Tail Risk	-14.10%

Reward TTM
Sharpe Ratio	-0.31
Alpha	-46.44

Character TTM
Hurst Exponent	0.454
Beta	0.938
Beta Downside	1.240

Drawdowns 3y
Max DD	82.26%
Mean DD	47.48%
Median DD	49.84%

Description: TBI TrueBlue October 29, 2025

TrueBlue, Inc. (NYSE:TBI) delivers workforce-solution services across the United States, Canada, the United Kingdom, Australia, and Puerto Rico through three operating segments: PeopleReady, PeopleManagement, and PeopleScout.

PeopleReady, the largest segment, supplies general, industrial, and skilled-trade contingent labor to construction, transportation, manufacturing, retail, hospitality, and energy firms, and historically generates roughly 70 % of the company’s revenue.

PeopleManagement focuses on on-site industrial staffing and commercial-driver services, operating under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands; it targets manufacturing, warehousing, distribution, and transportation customers that require managed labor pools.

PeopleScout offers recruitment-process outsourcing, talent-advisory, and managed-service-provider solutions, including the Affinix technology platform, employer-branding services, and compliance-monitoring programs for contingent-labor programs.

Key financial and market context (FY 2023): revenue of approximately $1.1 billion, adjusted EBITDA margin near 7 %, and a 4 % YoY increase in PeopleReady billings, driven by a sustained construction hiring boom and persistent labor-shortage pressures that favor contingent staffing models.

Sector-level drivers include a low-unemployment environment, rising wage inflation, and a projected 10 % CAGR growth in the U.S. recruitment-process-outsourcing market, all of which create tailwinds for TrueBlue’s diversified service lines.

For a deeper, data-driven view of TrueBlue’s valuation metrics, you might explore the analyst dashboards on ValueRay.

TBI Stock Overview

Market Cap in USD	147m
Sub-Industry	Human Resource & Employment Services
IPO / Inception	1996-06-13
Return 12m vs S&P 500	-38.8%
Analyst Rating	4.0 of 5

TBI Dividends

Currently no dividends paid

TBI Growth Ratios

CAGR 3y	-38.94%
CAGR/Max DD Calmar Ratio	-0.47
CAGR/Mean DD Pain Ratio	-0.82
Current Volume	122.6k
Average Volume	209k

Piotroski VR‑10 (Strict, 0-10) 0.5

Net Income (-28.1m TTM) > 0 and > 6% of Revenue (6% = 95.0m TTM)

FCFTA -0.08 (>2.0%) and ΔFCFTA -3.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 9.95% (prev 7.81%; Δ 2.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.05 (>3.0%) and CFO -34.9m <= Net Income -28.1m (YES >=105%, WARN >=100%)

Net Debt (106.5m) to EBITDA (1.23m) ratio: 86.53 <= 3.0 (WARN <= 3.5)

Current Ratio 2.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (29.9m) change vs 12m ago 0.65% (target <= -2.0% for YES)

Gross Margin 24.02% (prev 25.82%; Δ -1.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 227.4% (prev 238.3%; Δ -10.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -6.40 (EBITDA TTM 1.23m / Interest Expense TTM 4.27m) >= 6 (WARN >= 3)

Altman Z'' 3.60

(A) 0.23 = (Total Current Assets 313.2m - Total Current Liabilities 155.7m) / Total Assets 690.5m

(B) 0.47 = Retained Earnings (Balance) 326.1m / Total Assets 690.5m

(D) 0.79 = Book Value of Equity 304.3m / Total Liabilities 386.2m

Total Rating: 3.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 16.34

1. Piotroski 0.50pt = -4.50

2. FCF Yield -21.58% = -5.0

3. FCF Margin -3.45% = -1.30

4. Debt/Equity 0.42 = 2.42

5. Debt/Ebitda 86.53 = -2.50

6. ROIC - WACC (= -10.42)% = -12.50

7. RoE -9.17% = -1.53

8. Rev. Trend -77.82% = -5.84

9. EPS Trend -58.24% = -2.91

What is the price of TBI shares?

As of November 15, 2025, the stock is trading at USD 4.91 with a total of 122,600 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -11.37%, over three months by -15.64% and over the past year by -29.86%.

Is TrueBlue a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, TrueBlue (NYSE:TBI) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 16.34 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TBI is around 3.11 USD . This means that TBI is currently overvalued and has a potential downside of -36.66%.

Is TBI a buy, sell or hold?

TrueBlue has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy TBI.

Strong Buy: 1
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the TBI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	7.7	56.2%
Analysts Target Price	7.7	56.2%
ValueRay Target Price	3.4	-31.6%

TBI Fundamental Data Overview November 10, 2025

Market Cap USD = 147.0m (147.0m USD * 1.0 USD.USD)
P/E Forward = 56.1798
P/S = 0.0928
P/B = 0.5506
P/EG = 4.0048
Beta = 1.466
Revenue TTM = 1.58b USD
EBIT TTM = -27.4m USD
EBITDA TTM = 1.23m USD
Long Term Debt = 7.60m USD (from longTermDebt, last fiscal year)
Short Term Debt = 11.1m USD (from shortTermDebt, last quarter)
Debt = 126.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 106.5m USD (from netDebt column, last quarter)
Enterprise Value = 253.5m USD (147.0m + Debt 126.4m - CCE 19.9m)
Interest Coverage Ratio = -6.40 (Ebit TTM -27.4m / Interest Expense TTM 4.27m)
FCF Yield = -21.58% (FCF TTM -54.7m / Enterprise Value 253.5m)
FCF Margin = -3.45% (FCF TTM -54.7m / Revenue TTM 1.58b)
Net Margin = -1.78% (Net Income TTM -28.1m / Revenue TTM 1.58b)
Gross Margin = 24.02% ((Revenue TTM 1.58b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 22.70% (prev 23.61%)
Tobins Q-Ratio = 0.37 (Enterprise Value 253.5m / Total Assets 690.5m)
Interest Expense / Debt = 0.84% (Interest Expense 1.06m / Debt 126.4m)
Taxrate = -59.00% (out of range, set to none) (711.0k / -1.21m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.01 (Total Current Assets 313.2m / Total Current Liabilities 155.7m)
Debt / Equity = 0.42 (Debt 126.4m / totalStockholderEquity, last quarter 304.3m)
Debt / EBITDA = 86.53 (Net Debt 106.5m / EBITDA 1.23m)
Debt / FCF = -1.95 (negative FCF - burning cash) (Net Debt 106.5m / FCF TTM -54.7m)
Total Stockholder Equity = 306.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.07% (Net Income -28.1m / Total Assets 690.5m)
RoE = -9.17% (Net Income TTM -28.1m / Total Stockholder Equity 306.8m)
RoCE = -8.71% (EBIT -27.4m / Capital Employed (Equity 306.8m + L.T.Debt 7.60m))
RoIC = -5.32% (negative operating profit) (EBIT -27.4m / (Assets 690.5m - Curr.Liab 155.7m - Cash 19.9m))
WACC = 5.10% (E(147.0m)/V(273.4m) * Re(9.49%) + (debt cost/tax rate unavailable))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.92%
Fair Price DCF = unknown (Cash Flow -54.7m)
EPS Correlation: -58.24 | EPS CAGR: -62.02% | SUE: 0.05 | # QB: 0
Revenue Correlation: -77.82 | Revenue CAGR: -8.92% | SUE: 1.82 | # QB: 1

Additional Sources for TBI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle